nipradilol has been researched along with Disease Models, Animal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishida, K; Karim, MZ; Kawakami, H; Mizuno, K; Sawada, A; Yamamoto, T | 1 |
| Hirano, K; Ida, M; Kakizawa, H; Kojima, S; Matsui, F; Nakanishi, K; Okumura, A; Oohira, A; Sato, Y; Tokita, Y; Watanabe, M | 1 |
| Abeta, H; Akimoto, H; Harasawa, S; Ishii, T; Kanmatsuse, K; Koike, M; Kushiro, T; Okabe, T; Otsuka, Y; Sugiura, H | 1 |
| Izutani, S; Kim, S; Nakamura, Y; Omura, T; Takeuchi, K; Yoshida, K; Yoshikawa, J; Yoshiyama, M | 1 |
4 other study(ies) available for nipradilol and Disease Models, Animal
| Article | Year |
|---|---|
Neuroprotective effect of nipradilol [3,4-dihydro-8-(2-hydroxy-3-isopropylamino)-propoxy-3-nitroxy-2H-1-benzopyran] in a rat model of optic nerve degeneration.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Cell Count; Cell Survival; Disease Models, Animal; Intraocular Pressure; Male; Nerve Degeneration; Neuroprotective Agents; Optic Nerve Injuries; Propanolamines; Rats; Rats, Wistar; Retinal Ganglion Cells | 2009 |
Neuroprotective effect of nipradilol, an NO donor, on hypoxic-ischemic brain injury of neonatal rats.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Hypoxia-Ischemia, Brain; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Propanolamines; Rats; Rats, Sprague-Dawley | 2007 |
[The effect of exogenous nitric oxide on endothelial dysfunction in two-kidney, one-clip renovascular hypertensive rats].
Topics: Acetylcholine; Animals; Blood Pressure; Calcimycin; Disease Models, Animal; Endothelium, Vascular; Hypertension, Renovascular; In Vitro Techniques; Male; Nitric Oxide; Nitric Oxide Donors; Propanolamines; Rats; Rats, Wistar; Vasodilation | 2000 |
Nipradilol can prevent left ventricular systolic and diastolic dysfunction after myocardial infarction in rats.
Topics: Adrenergic beta-Antagonists; Animals; Atrial Natriuretic Factor; Biomarkers; Collagen Type I; Collagen Type III; Disease Models, Animal; Echocardiography, Doppler; Myocardial Infarction; Natriuretic Peptide, Brain; Propanolamines; Rats; Rats, Wistar; RNA, Messenger; Ventricular Dysfunction, Left; Ventricular Remodeling | 2002 |